The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2016

Filed:

Apr. 03, 2014
Applicant:

Arrowhead Research Corporation, Pasadena, CA (US);

Inventors:

John M. Yanni, Burleson, TX (US);

Jon E. Chatterton, Aliso Viejo, CA (US);

Diane Michelle Senchyna, Corona del Mar, CA (US);

Daniel A. Gamache, Arlington, TX (US);

Steven T. Miller, Arlington, TX (US);

Assignee:

Arrowhead Pharmaceuticals, Inc., Pasadena, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 31/7088 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); C12N 15/1137 (2013.01); C12N 2310/14 (2013.01); C12N 2320/30 (2013.01);
Abstract

RNA interference is provided for inhibition of tumor necrosis factor α (TNFα) by silencing TNFα cell surface receptor TNF receptor-1 (TNFR1) mRNA expression, or by silencing TNFα converting enzyme (TACE/ADAM17) mRNA expression. Silencing such TNFα targets, in particular, is useful for treating patients having a TNFα-related condition or at risk of developing a TNFα-related condition such as the ocular conditions dry eye, allergic conjunctivitis, or ocular inflammation, or such as dermatitis, rhinitis, or asthma, for example.


Find Patent Forward Citations

Loading…